These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15841777)

  • 41. Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double-blind, placebo-controlled, clinical trials.
    Vlachopoulos C; Oelke M; Maggi M; Mulhall JP; Rosenberg MT; Brock GB; Esler A; Büttner H
    Int J Clin Pract; 2015 Dec; 69(12):1496-507. PubMed ID: 26299520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.
    Roehrborn CG; Egan KB; Miner MM; Ni X; Wong DG; Rosen RC
    BJU Int; 2016 Jul; 118(1):153-60. PubMed ID: 26765325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
    Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
    Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tadalafil - a therapeutic option in the management of BPH-LUTS.
    Carson CC; Rosenberg M; Kissel J; Wong DG
    Int J Clin Pract; 2014 Jan; 68(1):94-103. PubMed ID: 24341303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between international prostate symptom score and uroflowmetry in patients with benign prostatic hyperplasia.
    Oranusi CK; Nwofor AE; Mbonu O
    Niger J Clin Pract; 2017 Apr; 20(4):454-458. PubMed ID: 28406126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparison of self-estimation of disuric disorders gauged IPSS scale and qualities of lives QoL with self-estimation of sexual life gauged by IIEF-5 scale].
    Lipczyński W; Dobrowolska-Glazar B; Dobrowolski ZF
    Przegl Lek; 2012; 69(6):247-52. PubMed ID: 23094437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Men with Hypertension are More Likely to Have Severe Lower Urinary Tract Symptoms and Large Prostate Volume.
    Hwang EC; Kim SO; Nam DH; Yu HS; Hwang I; Jung SI; Kang TW; Kwon DD; Kim GS
    Low Urin Tract Symptoms; 2015 Jan; 7(1):32-6. PubMed ID: 26663649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of tamsulosin hydrochloride on lower urinary tract symptoms and quality of life in patients with benign prostatic hyperplasia. Evaluation using bother score.
    Yoshida M; Sugiyama Y; Masunaga K; Maeda Y; Satoji Y; Nagata T; Inadome A
    Drugs Today (Barc); 2007 Jun; 43 Suppl B():1-7. PubMed ID: 17612712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of the Patient Perception of Intensity of Urgency Scale in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Mathias SD; Crosby RD; Nazir J; Klaver M; Drogendijk T; Hakimi Z; Odeyemi IA
    Value Health; 2014 Dec; 17(8):823-9. PubMed ID: 25498777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.
    Kardasevic A; Milicevic S
    Med Arch; 2017 Feb; 71(1):32-36. PubMed ID: 28428671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of urinary incontinence and lower urinary tract symptoms for community-dwelling elderly 85 years of age and older.
    Song HJ; Bae JM
    J Wound Ostomy Continence Nurs; 2007; 34(5):535-41. PubMed ID: 17876216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship among diet habit and lower urinary tract symptoms and sexual function in outpatient-based males with LUTS/BPH: a multiregional and cross-sectional study in China.
    Chen Y; Yu W; Zhou L; Wu S; Yang Y; Wang J; Tian Y; He D; Xu Y; Huang J; Wang X; Gao X; Li H; Ma L; Zhang N; Zhao S; Jin X
    BMJ Open; 2016 Aug; 6(8):e010863. PubMed ID: 27580828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia.
    Donovan JL; Kay HE; Peters TJ; Abrams P; Coast J; Matos-Ferreira A; Rentzhog L; Bosch JL; Nordling J; Gajewski JB; Barbalias G; Schick E; Silva MM; Nissenkorn I; de la Rosette JJ
    Br J Urol; 1997 Nov; 80(5):712-21. PubMed ID: 9393291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Older women and men with urinary symptoms.
    Stenzelius K; Westergren A; Mattiasson A; Hallberg IR
    Arch Gerontol Geriatr; 2006; 43(2):249-65. PubMed ID: 16384617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Investigation of lower urinary tract symptoms in urological outpatients using original IPSS plus post micturition dribble questionnaire].
    Hanai T; Matsumoto S; Shimizu N; Uemura H; Sugiyama T
    Nihon Hinyokika Gakkai Zasshi; 2008 Nov; 99(7):723-8. PubMed ID: 19068688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
    J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simple case definition of clinical benign prostatic hyperplasia, based on International Prostate Symptom Score, predicts general practitioner consultation rates.
    Kok ET; Bohnen AM; Jonkheijm R; Gouweloos J; Groeneveld FP; Thomas S; Bosch JL
    Urology; 2006 Oct; 68(4):784-9. PubMed ID: 17070353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia.
    Barry MJ
    Urology; 2001 Dec; 58(6 Suppl 1):25-32; discussion 32. PubMed ID: 11750246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.